Literature DB >> 19227798

Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act.

Elizabeth Popp Berman1.   

Abstract

This paper draws on institutional theory to explain the rise of university patenting in the USA. While observers have traditionally attributed this development to the Bayh-Dole Act of 1980, recent research has shown that university patenting was increasing throughout the 1970s and argued that the Act's impact was less than has generally been assumed. This paper attempts to reconcile these opposing positions by explaining the rise of university patenting as a process of institution-building. Beginning in the 1960s, a skilled actor within the federal bureaucracy created a proto-institution that simplified university patenting and encouraged the development of a community of university patent administrators. In the 1970s, that community in turn allied itself with government proponents of patent policy liberalization and representatives of small business in a successful effort to pass the Bayh-Dole Act. The Act itself should be seen not as creating modern technology transfer, but rather as a final step in a state-driven process of institutionalization that was already well under way by 1980. The case is used to discuss how an institutional approach, which is infrequently seen in STS, can sometimes be useful to it.

Mesh:

Year:  2008        PMID: 19227798     DOI: 10.1177/0306312708098605

Source DB:  PubMed          Journal:  Soc Stud Sci        ISSN: 0306-3127            Impact factor:   3.885


  6 in total

1.  Patenting and the gender gap: should women be encouraged to patent more?

Authors:  Inmaculada de Melo-Martín
Journal:  Sci Eng Ethics       Date:  2012-01-03       Impact factor: 3.525

2.  Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act.

Authors:  Alessandra Colaianni; Robert Cook-Deegan
Journal:  Milbank Q       Date:  2009-09       Impact factor: 4.911

Review 3.  Patents in genomics and human genetics.

Authors:  Robert Cook-Deegan; Christopher Heaney
Journal:  Annu Rev Genomics Hum Genet       Date:  2010       Impact factor: 8.929

4.  Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000.

Authors:  Farah Huzair; Steve Sturdy
Journal:  Stud Hist Philos Biol Biomed Sci       Date:  2017-05-13

5.  Personalised Medicine and the Economy of Biotechnological Promise.

Authors:  Steve Sturdy
Journal:  New Bioeth       Date:  2017-04

6.  The Nomos of the University: Introducing the Professor's Privilege in 1940s Sweden.

Authors:  Ingemar Pettersson
Journal:  Minerva       Date:  2018-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.